Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCRT: VSF1.01 for the Reduction of Cochlear Implant Surgery Related Trauma
NCT06545175Phase 2Active, not recruiting
- Sponsor
- Hannover Medical School
- Start
- Nov 2024
- Primary completion
- Oct 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of VSF1.01 in hearing loss, sponsored by Hannover Medical School. Started Nov 2024; status: active, not recruiting.
02
Drugs
VSF1.01
03
Conditions
hearing loss
Beyond the preview
Go deeper on NCT06545175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06545175.